Stavroula Masouridi-Levrat

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Chronic Myeloid Leukemia

Stem Cell Transplantation

Respiratory Syndrome Coronavirus

Top Venues

Bone marrow transplantation

This page only lists publications with an associated author ORCID identifier.

Publications

Zuleika Calderin Sollet, Antonia Schäfer, Sylvie Ferrari-Lacraz, Stavroula Masouridi-Levrat, Anne-Claire Mamez, Amandine Pradier, Federico Simonetta, Yves Chalandon, Jean Villard, Stéphane Buhler
CMV serostatus and T-cell repertoire diversity 5 years after allogeneic hematopoietic stem cell transplantation. Leukemia (2023)
Silvio Ragozzino, Nicolas J Mueller, Dionysios Neofytos, Jakob R Passweg, Antonia Müller, Michael Medinger, Christian Van Delden, Stavroula Masouridi-Levrat, Yves Chalandon, Sarah Tschudin-Sutter, Nina Khanna, null null
Epidemiology, outcomes and risk factors for recurrence of Clostridioides difficile infections following allogeneic hematopoietic cell transplantation: a longitudinal retrospective multicenter study. Bone marrow transplantation (2023)
Stavroula Masouridi-Levrat, Eduardo Olavarria, Simona Iacobelli, Mahmoud Aljurf, Elena Morozova, Riitta Niittyvuopio, Henrik Sengeloev, Peter Reményi, Grzegorz Helbig, Paul Browne, Arnold Ganser, Arnon Nagler, John A Snowden, Marie Robin, Jakob Passweg, Gwendolyn Van Gorkom, Hélène Labussière Wallet, Jennifer Hoek, Henric-Jan Blok, Theo De Witte, Nicolaus Kroeger, Patrick J Hayden, Yves Chalandon, Ibrahim Yakoub Agha
Outcomes and toxicity of allogeneic hematopoietic cell transplantation in chronic myeloid leukemia patients previously treated with second-generation tyrosine kinase inhibitors: a prospective non-interventional study from the Chronic Malignancy Working Party of the EBMT. Bone marrow transplantation (2021)
Anne-Claire Mamez, Amandine Pradier, Federica Giannotti, Adrien Petitpas, Marta Fabra Urdiola, Diem-Lan Vu, Stavroula Masouridi-Levrat, Sarah Morin, Carole Dantin, Dominique Clerc-Renaud, Christiane S Eberhardt, Laurent Kaiser, Federico Simonetta, Yves Chalandon
Antibody responses to SARS-CoV2 vaccination in allogeneic hematopoietic stem cell transplant recipients. Bone marrow transplantation 56 (12) (2021)
Yan Beauverd, Sarah Morin, Caroline Stephan, Carmen De Ramon Ortiz, Marta Fabra Urdiola, Federica Giannotti, Elif Mahne, Anne-Claire Mamez, Maria Mappoura, Federico Simonetta, Thien-An Tran, Christian Ayer, Sarah Noetzlin, Isaline Verdon, Stavroula Masouridi-Levrat, Yves Chalandon
The EBMT Cytogenetic Risk Score maintains its prognostic significance in acute myeloid leukemia following allogeneic stem cell transplantation in a cohort with 40% of patients transplanted with in vitro partial T-cell depleted graft. Bone marrow transplantation 56 (9) (2021)